Showing results (271-280 of 322) with videos related to
Sort By:
Pageof 33
European Journal of Immunology|April 1, 1990
Interleukin 2 receptor-targeted cytotoxicity. Receptor binding requirements for entry of a diphtheria toxin-related interleukin 2 fusion protein into cellsC A Waters, P A Schimke, C E Snider, et al.European Journal of Immunology|March 1, 1992
Interleukin 2 receptor targeted fusion toxin (DAB486-IL-2) treatment blocks diabetogenic autoimmunity in non-obese diabetic miceA Pacheco-Silva, M G Bastos, R A Muggia, et al.Transplantation|December 1, 1985
The effect of anti-interleukin-2 receptor monoclonal antibody on allograft rejectionR L Kirkman, L V Barrett, G N Gaulton, et al.Inflammatory Bowel Diseases|January 10, 2001
Heritable susceptibility for colitis in mice induced by IL-10 deficiencyI J Bristol, M A Farmer, Y Cong, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1997
A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD miceX X Zheng, A W Steele, W W Hancock, et al.Cellular Immunology|June 1, 1985
Behavior of helper T lymphocytes in cyclosporine-mediated long-term graft acceptance in the ratJ W Kupiec-Weglinski, C D Heidecke, J L Araujo, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 24, 1998
Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fc gamma2a protein blocks delayed-type hypersensitivityY S Kim, W Maslinski, X X Zheng, et al.Nephron|January 1, 1976
Secondary hyperparathyroidism in human kidney transplant recipientsP G Pletka, T B Strom, C L Hampers, et al.Clinical Immunology and Immunopathology|November 1, 1985
Investigation of in vivo activated T cells in multiple sclerosis and inflammatory central nervous system diseasesD A Hafler, M E Hemler, L Christenson, et al.Human Immunology|December 1, 1987
Antigen specificity of mixed lymphocyte response-induced suppressor cellsL A Turka, E L Ramos, J E Leggat, et al.Pageof 33